1,2,4-Oxadiazol-3-amine, 5-((2,6-dichlorophenyl)methyl)- → HCID 54050783, Verbindung

HRID 1733479Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1733479
[NH2:1][C:2]1[N:6]=[C:5]([CH2:7][C:8]2[C:13]([Cl:14])=[CH:12][CH:11]=[CH:10][C:9]=2[Cl:15])[O:4][N:3]=1.[CH:16]([O-])([O-])[O:17][CH2:18][CH3:19]>>[CH2:18]([O:17][CH:16]=[N:1][C:2]1[N:6]=[C:5]([CH2:7][C:8]2[C:13]([Cl:14])=[CH:12][CH:11]=[CH:10][C:9]=2[Cl:15])[O:4][N:3]=1)[CH3:19]

Komponenten

3

Edukt 2

HCID 27431271,2,4-Oxadiazol-3-amine, 5-((2,6-dichlorophenyl)methyl)-HCID 53630039Ethylorthoformate2×

Produkt 1

HCID 54050783HCID 54050783, Verbindung

Versuchsvorschrift

1 g of 3-amino-5-(2,6-dichlorobenzyl)-1,2,4-oxadiazole is heated in air at 150° C. for 3 hours with a few ml of ethyl orthoformate in an amount which is just sufficient to ensure slight agitation. The excess ethyl orthoformate is driven off under reduced pressure. The residue is crystallised from ether.

Aufarbeitung

  1. customThe residue is crystallised from ether

Quellen und Nachweise

ORD-Eintrag
ord-614384af29274804a55aacaf18eba29c
Quelldatensatz
uspto-grants-1980_12
Patentnummer
US04242352

Notizen zur Reaktion

Wird geladen…